IRF1 is a master regulator of type 1 eosinophils
Journal of Allergy and Clinical Immunology · 2026-05 · 157 (5) · 1031-1033
DOI: 10.1016/j.jaci.2026.02.042 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-05. Verfasst von Immaculeta Osuji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
- Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati, Ohio. Electronic address:…
Förderung
- National Heart Lung and Blood Institute
Zitieren
APA
Osuji, I., & Zimmermann, N. (2026). IRF1 is a master regulator of type 1 eosinophils. Journal of Allergy and Clinical Immunology, 157(5), 1031-1033. https://doi.org/10.1016/j.jaci.2026.02.042
Vancouver
Osuji I, Zimmermann N. IRF1 is a master regulator of type 1 eosinophils. Journal of Allergy and Clinical Immunology. 2026;157(5):1031-1033. doi:10.1016/j.jaci.2026.02.042
BibTeX
@article{Osuji2026,
author = {Osuji, Immaculeta and Zimmermann, Nives},
title = {IRF1 is a master regulator of type 1 eosinophils},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {157},
number = {5},
pages = {1031--1033},
doi = {10.1016/j.jaci.2026.02.042}
}
EUVIMED